Judgment you
can act on

A New York-based machine learning company developing enterprise automation tools needed to diversify its capital sources beyond venture funding. Themis identified three overlapping federal grant programs, structured the applications to emphasize workforce impact and national competitiveness criteria, and coordinated compliance architecture to maintain eligibility across all three simultaneously. The company secured $4.2M in non-dilutive funding within nine months.

An adaptive learning platform preparing for market expansion faced conflicting regulatory requirements across three target states, each with distinct data privacy, curriculum alignment, and vendor certification standards. Themis conducted a comprehensive feasibility assessment, identified a sequencing strategy that leveraged early approvals to accelerate later ones, and managed the licensing process across all three jurisdictions. Full operational licensure was achieved in fourteen months — six months ahead of the client's internal projection.

A mid-market manufacturer receiving CHIPS Act incentives was flagged for a compliance review related to workforce reporting discrepancies. Themis conducted an independent internal audit, identified the root cause — a systems integration gap between HR and compliance reporting — and prepared the remediation package and response to the reviewing agency. The company received full clearance with no penalties and implemented controls to prevent recurrence.

A private infrastructure fund evaluating a portfolio of clean energy investments across the Northeast needed an independent assessment of regulatory risk before committing capital. Themis's review uncovered a permitting timeline conflict that would have triggered penalty clauses in two of five target deals, representing $18M in potential exposure. The fund restructured its entry sequencing based on our assessment, avoided the exposure, and proceeded to close three of the five deals on revised terms.